Printer Friendly
The Free Library
14,495,914 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Takara Bio Confirms that Kelp-derived Fucoidan Inhibits Clot Formation.


Tokyo, Japan, June 9, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Takara Bio has identified a unique property of fucoidan derived from Kjellmaniella crassifolia, a kind of giant kelp, in collaboration with the University of Saskatchewan The University of Saskatchewan (U of S) is a coeducational public research university located on the east side of the South Saskatchewan River in Saskatoon, Saskatchewan, Canada. The University is celebrating its centennial year in 2007.  in Canada.

Specifically, the two partners have confirmed that high-molecular-weight fucoidan in Kjellmaniella crassifolia, which has an average molecular weight of 200,000, can inhibit the clot formation.

The results of mice experiment showed that fucoidan adheres to artery and vein endothelial cells Endothelial cells
The cells lining the inner walls of the blood vessels.

Mentioned in: Von Willebrand Disease
, helping prevent blood from clotting clotting /clot·ting/ (klot´ing) coagulation (1).

clotting

the formation of a jellylike substance over the ends or within the walls of a blood vessel, with resultant stoppage of the blood flow.
 in veins and arteries. In addition, they also indicated that the clot formation is effectively inhibited when polysaccharide polysaccharide: see carbohydrate.
polysaccharide

Any of a large class of long-chain sugars composed of monosaccharides. Because the chains may be unbranched or branched and the monosaccharides may be of one, two, or occasionally more kinds,
 is highly sulfated.

Fucoidan obtained from Kjellamaniella crassifolia contains a higher level of sulfated polysaccharide than fucoidan derived from other types of kelp. Going forward, Takara Bio will proceed with research on fucoidan as a promising material for functional foods.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 10, 2006
Words:147
Previous Article:POLA Discovers Bush Clover Polyphenol Has Whitening Effect.
Next Article:Daiichi Sankyo Healthcare to Market New OTC Gastrointestinal Drug.



Related Articles
Takara Bio Discovers Seven New RNA Interference Enzymes.
Takara Bio Establishes Efficient Method to Produce Polyterpene, Tumor Growth Inhibitor.
Takara Bio Sheds Light on Anti-inflammatory Mechanism of Agaro-oligosaccharide.
Takara Bio Sets up New Research Division at Institute for Protein Research, Osaka University.
Takara Bio, MolMed Announce That Phase I/II Clinical Trial of HSV-TK Gene Therapy Delivers Positive Results.
Takara Bio to Release Real-Time PCR System in April.
Takara Bio Chinese Subsidiary to Expand Lines of Business, Files Chinese Clinical Trial Application.
Takara Bio to Release Two New Enzymes.
Takara Bio, Chinese CDC to Collaborate in AIDS Research.
Takara Bio Licenses FLT3 Gene Mutation Detection Method to InVivoScribe Technologies.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles